IGM Biosciences Inc reports results for the quarter ended in December - Earnings Summary

IGM Biosciences

29/03/2022 12:55

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly
adjusted loss
of $1.50​​ per share for the quarter ended in December. The mean
expectation of nine analysts for the quarter was for a loss of
$1.54 per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * IGM Biosciences Inc's reported EPS for the quarter was a
loss of
$1.50​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IGM Biosciences Inc shares had fallen by 48.9% this
quarter.
    * The company reported a quarterly loss of $50.64 million.
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 29 at 11:55 a.m.  ​All
figures in US dollars unless otherwise stated